JO
INDV icon

John Overdeck’s Indivior Pharmaceuticals INDV Stock Holding History

John Overdeck’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
312,005
+136,238
+78% +$4.94M 0.01% 1332
2026
Q1 		$5.36M Buy
175,767
+60,790
+53% +$2.01M ﹤0.01% 1928
2025
Q4 		$4.13M Sell
114,977
-30,857
-21% -$942K 0.01% 1884
2025
Q3 		$3.52M Buy
145,834
+103,243
+242% +$2.16M 0.01% 1737
2025
Q2 		$628K Buy
42,591
+8,114
+24% +$94.5K ﹤0.01% 2482
2025
Q1 		$329K Sell
34,477
-76,403
-69% -$803K ﹤0.01% 2679
2024
Q4 		$1.38M Buy
110,880
+2,237
+2% +$23K ﹤0.01% 1967
2024
Q3 		$1.06M Buy
108,643
+60,068
+124% +$704K ﹤0.01% 2088
2024
Q2 		$783K Buy
48,575
+28,312
+140% +$511K ﹤0.01% 2121
2024
Q1 		$434K Buy
+20,263
New +$381K ﹤0.01% 2399

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's INDV Position: Q2 2026 in Review

John Overdeck increased its Indivior Pharmaceuticals (INDV) stake by 78% in Q2 2026, buying an estimated $4.94M and bringing the position to 312,005 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #1332.

John Overdeck first reported a position in INDV in Q1 2024 and has held it in 10 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • John Overdeck held 312,005 shares of Indivior Pharmaceuticals worth $12.8M as of Q2 2026.
  • John Overdeck bought 136,238 Indivior Pharmaceuticals shares in Q2 2026, an estimated $4.94M.
  • Indivior Pharmaceuticals made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1332 holding.
  • John Overdeck first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.